We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




New Nano Technique Rapidly Inserts Nucleic Acids into Cells

By LabMedica International staff writers
Posted on 27 Apr 2015
Print article
Image: Optical micrograph of human cells (green) impaled on the nanoneedles (orange). The nanoneedles have injected DNA into the cells’ nuclei (blue) (Photo courtesy of Imperial College London).
Image: Optical micrograph of human cells (green) impaled on the nanoneedles (orange). The nanoneedles have injected DNA into the cells’ nuclei (blue) (Photo courtesy of Imperial College London).
Researchers have unveiled a novel technique for inserting nucleic acids into cells that is based on biodegradable silicon-based "nanoneedles."

The porous nanoneedles act like a sponge to transport nucleic acids significantly better than similarly sized solid structures. The needles deliver their load by penetrating the cell's outer membrane without harming or killing the cell. The nanoneedles are made from biodegradable silicon that degrades in about two days, leaving behind only a negligible amount of nontoxic orthosilicic acid.

Investigators at Imperial College London (United Kingdom) and Houston Methodist Research Institute (TX, USA) used nanoneedle technology to deliver DNA and siRNA into human cells growing in culture and into the back muscles of mice. They reported in the March 30, 2015, online edition of the journal Nature Materials that seven days following insertion of the VEGF (vascular endothelial growth factor)-165 gene into the mouse back muscles there was a six-fold increase in the formation of new blood vessels, and blood vessels continued to form over a 14 day period. The technique did not seem to cause inflammation or other apparent harmful side effects.

"This is a quantum leap compared to existing technologies for the delivery of genetic material to cells and tissues," said senior author Dr. Ennio Tasciotti, professor of nanomedicine at Houston Methodist Research. "By gaining direct access to the cytoplasm of the cell we have achieved genetic reprogramming at an incredible high efficiency. This will let us personalize treatments for each patient, giving us endless possibilities in sensing, diagnosis and therapy. And all of this thanks to tiny structures that are up to 1,000 times smaller than a human hair."

Contributing author Dr. Molly Stevens, professor of bioengineering at Imperial College London, said, "It is still very early days in our research, but we are pleased that the nanoneedles have been successful in this trial in mice. There are a number of hurdles to overcome and we have not yet trialled the nanoneedles in humans, but we think they have enormous potential for helping the body to repair itself."

Related Links:

Imperial College London
Houston Methodist Research Institute


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.